Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
A diversified investment strategy spreads risk across various assets. Understand its benefits and how it can help secure your financial future.
22,620 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Berkshire Hathaway disclosed a $2.65 billion stake in Delta Air Lines, marking a sharp shift from Buffett-era airline...
As AI builds out more data centers, the U.S. power grid faces mounting strain. HPE’s warning of a looming 19 gigawatt...
Sberbank plans a crypto wallet and digital depository within its app ecosystem by December, a move aimed at bringing ...
Trinidad and Tobago signed two memorandums of understanding with U.S. firms to move forward with large-scale data cen...
As spacemobile nears commercial launch, investors wonder if this space-based cellular plan can disrupt the market. Th...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
Fox Factory's Q4 2025 results shed light on demand for high-performance suspensions and the company’s margin discipli...
A niche battery company moved sharply higher as growth signals and product milestones drew investor attention. This a...
Oil prices rose as the IEA deployed an historic stock draw, yet Carlyle Group’s Currie argued there’s policy response...
A relative says six figures are missing after an aunt’s attorney seized control of her finances, aided by doctors who...
As housing markets shift, investors wonder if Opendoor can deliver a meaningful stock reaction by 2026. This guide br...